Tumor angiogenesis and drug resistance
Despite partial success in cancer therapy in the last decades treatment of already metastasized or inoperable tumors is still not sufficient. Especially drug
tumorangio
Hypoxia angiogenesis and cancer therapy: To breathe or not to
29 Apr 2009 blood vessels because neo-angiogenesis ... therapy aim at “suffocating” the tumor ... Hypoxia angiogenesis and cancer therapy.
Dual-Action Combination Therapy Enhances Angiogenesis while
12 Jan 2015 Increasing chemotherapy delivery to tumors while enhancing drug uptake and reducing side effects
Angiogenesis inhibitors in cancer therapy: mechanistic perspective
15 May 2013 Angiogenesis a process of new blood vessel formation
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
5 Apr 2021 Most of the anti-angiogenic agents approved for cancer treatment rely on targeting vascular endothelial growth factor (VEGF) actions as VEGF ...
Tumor Angiogenesis: A Key Target for Cancer Therapy
28 Mar 2018 Tumor Angiogenesis: A Key Target for Cancer Therapy. Dieter Marmé ... angiogenics in the treatment of several tumor types. Furthermore we.
Antiâ•'CD73 therapy impairs tumor angiogenesis
Tumor levels of vascular endothelial growth factor (VEGF) were reduced and tumor angiogenesis suppressed in a breast cancer mouse model following treatment with
Anti-angiogenic Cancer Therapy: Development of Resistance
Tumor angiogenesis is regu- lated by numerous “classic” pro-angiogenic factors including fibroblast growth factor-2 (FGF-2)
Angiogenesis in cancer: anti-VEGF escape mechanisms
Keywords: Vascular endothelial growth factor (VEGF); angiogenesis; cancer; such anti-angiogenic therapy and those tumors that initially.
PB R
Dual-Action Combination Therapy Enhances Angiogenesis while
12 Jan 2015 Increasing chemotherapy delivery to tumors while enhancing drug uptake and reducing side effects
S ( ) X
- angiogenic therapy cancer
- angiogenesis cancer treatment
- anti-angiogenic cancer therapy
- angiogenesis targeted cancer therapy
- anti-angiogenesis cancer therapy
- targeting angiogenesis in cancer therapy moving beyond vascular endothelial growth factor
- anti-angiogenesis-based cancer therapy
- angiogenesis inhibitor cancer gene therapy